Trials / Completed
CompletedNCT05728918
Effectiveness of Antrodia Cinnamomea Mycelia on Improving Immune Response in Subhealth People
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Greenyn Biotechnology Co., Ltd. · Industry
- Sex
- All
- Age
- 50 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This study aims to assess the effect of Antrodia cinnamomea mycelia on immune modulation in subhealth people.
Detailed description
This study aims to assess the effect of Antrodia cinnamomea mycelia on immune modulation in subhealth people: a randomized, double-blind, placebo-controlled, and parallel clinical investigation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Antrodia cinnamomea mycelia | Antrodia cinnamomea mycelia capsule, two capsules/day (600 mg/day) for 3 months |
| DIETARY_SUPPLEMENT | Placebo | Placebo capsule, two capsules/day (600 mg/day) for 3 months |
Timeline
- Start date
- 2023-03-01
- Primary completion
- 2024-02-29
- Completion
- 2024-05-30
- First posted
- 2023-02-15
- Last updated
- 2024-08-09
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05728918. Inclusion in this directory is not an endorsement.